Trademark: 90610837
Status Date
Thursday, January 4, 2024
Filing Date
Monday, March 29, 2021
Published for Opposition
Tuesday, December 7, 2021
5 Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory, dermatological and autoimmune disorders
16 Printed publications, namely, brochures, newsletters, and pamphlets relating to medical issues, procedures, disease symptoms, patient support and community building
44 Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, inflammatory, metabolic and dermatological disorders
Jan 6, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2024
Sou Extension 4 Granted
Jan 4, 2024
Sou Extension 4 Filed
Jan 4, 2024
Sou Teas Extension Received
Jul 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2023
Sou Extension 3 Granted
Jul 14, 2023
Sou Extension 3 Filed
Jul 14, 2023
Sou Teas Extension Received
Jan 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 12, 2023
Sou Extension 2 Granted
Jan 12, 2023
Sou Extension 2 Filed
Jan 12, 2023
Sou Teas Extension Received
Jul 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 15, 2022
Sou Extension 1 Granted
Jul 15, 2022
Sou Extension 1 Filed
Jul 15, 2022
Sou Teas Extension Received
May 10, 2022
Assigned To Examiner
Feb 1, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 7, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 7, 2021
Published For Opposition
Nov 17, 2021
Notification Of Notice Of Publication E-Mailed
Nov 1, 2021
Approved For Pub - Principal Register
Nov 1, 2021
Examiner's Amendment Entered
Nov 1, 2021
Notification Of Examiners Amendment E-Mailed
Nov 1, 2021
Examiners Amendment E-Mailed
Nov 1, 2021
Examiners Amendment -Written
Oct 25, 2021
Assigned To Examiner
Jul 6, 2021
New Application Office Supplied Data Entered
Apr 1, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24